Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Coronary patency after thrombolysis

F Van de Werf1

  • 1Department of Cardiology, University Hospital Gasthuisberg, Leuven, Belgium.

Zeitschrift Fur Kardiologie
|January 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

RNA Profiling in Human and Murine Transplanted Hearts: Identification and Validation of Therapeutic Targets for Acute Cardiac and Renal Allograft Rejection.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2015
Same author

Dabigatran versus warfarin in patients with mechanical heart valves: reply.

Journal of thrombosis and haemostasis : JTH·2014
Same author

Pre-hospital treatment of STEMI patients. A scientific statement of the Working Group Acute Cardiac Care of the European Society of Cardiology.

Acute cardiac care·2011
Same author

Departures from the protocol during conduct of a clinical trial: a pattern from the data record consistent with a learning curve.

Quality & safety in health care·2010
Same author

[Implementation of reperfusion therapy in ST segment elevation myocardial infarction (STEMI). A policy statement from the Belgian Society of Cardiology and its working group of acute cardiology and interventional cardiology].

Revue medicale de Bruxelles·2010
Same author

[Implementation of reperfusion therapy in ST segment elevation myocardial infarction (STEMI). A policy statement from the Belgian Society of Cardiology and its working group of acute cardiology and interventional cardiology].

Revue medicale de Liege·2010
Same journal

[Not Available].

Zeitschrift fur Kardiologie·2016
Same journal

[Not Available].

Zeitschrift fur Kardiologie·2016
Same journal

[On pathogenesis of coronary heart disease].

Zeitschrift fur Kardiologie·2016
Same journal

An overview of the evolution of the atherosclerotic plaque: from fatty streak to plaque rupture and thrombosis.

Zeitschrift fur Kardiologie·2016
Same journal

[Not Available].

Zeitschrift fur Kardiologie·2016
Same journal

[Reconstructive surgery of the aortic root].

Zeitschrift fur Kardiologie·2016
See all related articles

Rapid reperfusion therapy aims to reopen blocked coronary arteries. While recombinant tissue plasminogen activator (rt-PA) excels in early recanalization, all fibrinolytic agents show similar coronary artery patency rates by hospital discharge.

Area of Science:

  • Cardiology
  • Pharmacology
  • Thrombosis Research

Background:

  • Thrombolytic therapy is crucial for restoring blood flow in myocardial infarction.
  • Coronary artery recanalization is the primary goal of acute treatment.

Purpose of the Study:

  • To summarize coronary patency rates from thrombolytic therapy trials.
  • To compare the effectiveness of different fibrinolytic agents over time.

Main Methods:

  • Systematic review and summarization of placebo-controlled and comparative trials.
  • Analysis of coronary patency rates at various time points post-treatment initiation.

Main Results:

  • Recombinant tissue plasminogen activator (rt-PA) demonstrated superior early reperfusion rates.

Related Experiment Videos

  • At hospital discharge, patency rates were comparable across different fibrinolytic agents.
  • Observed patency rates at discharge did not differ significantly from antithrombotic treatment alone.

    • Conclusions:

    • Early reperfusion efficacy varies among thrombolytic agents, with rt-PA being more effective.
    • Long-term patency rates are similar regardless of the fibrinolytic agent used.
    • Further research into novel approaches is needed to enhance early reperfusion rates.